|
1-[2-[(4-fluorophenyl)methylamino]-2-oxo-ethyl]-N-[1-(4-methyl-5-vinyl-1H-imidazol-2-yl)ethyl]-6-oxo-pyridine-3-carboxamide |
|
Mycobacterium |
Exoenzyme |
Preclinical (in vitro) |
Mori M, et al. 2014. Bioorg Med Chem Lett |
|
Fusaric acid |
Depiction based on curated SMILES
H
3
C
N
O
HO
|
Salmonella |
TTSS (SPI-1 encode) |
Preclinical (in vitro) |
Li J, et al. 2014. Biochem Biophys Res Commun |
|
(E)-N'-(3,5-Dibromo-2-hydroxybenzylidene)nicotinohydrazide |
Depiction based on curated SMILES
N
OH
Br
O
Br
N
N
H
|
Chlamydia Escherichia Salmonella |
TTSS (Type III secretion system) TTSS (Type III secretion system) TTSS (SPI-1 encode); TTSS (SPI-2 encode) |
Preclinical (in vitro) Preclinical (in vitro) Preclinical (in vitro) |
Bailey L, et al. 2007. FEBS Lett Tree JJ, et al. 2009. Infect Immun; Wang D, et al. 2011. J Biol Chem Negrea A, et al. 2007. Antimicrob Agents Chemother |
|
Nicotinic acid (5-bromo-2-hydroxy-benzylidene)-hydrazide |
Depiction based on curated SMILES
N
OH
O
Br
N
N
H
|
Salmonella Shigella |
TTSS (SPI-1 encode); TTSS (SPI-2 encode) TTSS (Type III secretion system) |
Preclinical (in vitro) Preclinical (in vitro) |
Negrea A, et al. 2007. Antimicrob Agents Chemother Veenendaal AK, et al. 2009. J Bacteriol |
|
5-cyano-6-[(4-methylphenyl)methylsulfanyl]pyridine-2-carboxylic acid |
Depiction based on curated SMILES
N
N
HO
O
CH
3
S
|
Escherichia Yersinia |
TTSS (Type III secretion system) TTSS (Type III secretion system) |
Preclinical (in vitro) Preclinical (in vitro) |
Pan NJ, et al. 2009. Antimicrob Agents Chemother
|
|
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |